Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A.
Panova EA, Kleymenov DA, Shcheblyakov DV, Bykonia EN, Mazunina EP, Dzharullaeva AS, Zolotar AN, Derkaev AA, Esmagambetov IB, Sorokin II, Usachev EV, Noskov AN, Ivanov IA, Zatsepin TS, Dmitriev SE, Gushchin VA, Naroditsky BS, Logunov DY, Gintsburg AL. Panova EA, et al. Among authors: bykonia en. Front Immunol. 2023 Feb 14;14:1098302. doi: 10.3389/fimmu.2023.1098302. eCollection 2023. Front Immunol. 2023. PMID: 36865543 Free PMC article.
Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation.
Mikhailov MI, Karlsen AA, Potemkin IA, Isaeva OV, Kichatova VS, Malinnikova EY, Asadi Mobarkhan FA, Mullin EV, Lopatukhina MA, Manuylov VA, Mazunina EP, Bykonia EN, Kleymenov DA, Popova LI, Gushchin VA, Tkachuk AP, Polyakov AD, Eladly AM, Solonin SA, Gordeychuk IV, Kyuregyan KK. Mikhailov MI, et al. Among authors: bykonia en. Viruses. 2022 Dec 22;15(1):37. doi: 10.3390/v15010037. Viruses. 2022. PMID: 36680077 Free PMC article.
A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels.
Kleymenov DA, Bykonia EN, Popova LI, Mazunina EP, Gushchin VA, Kolobukhina LV, Burgasova OA, Kruzhkova IS, Kuznetsova NA, Shidlovskaya EV, Divisenko EV, Pochtovyi AA, Bacalin VV, Smetanina SV, Tkachuk AP, Logunov DY, Gintsburg AL. Kleymenov DA, et al. Among authors: bykonia en. Front Immunol. 2021 Nov 9;12:771609. doi: 10.3389/fimmu.2021.771609. eCollection 2021. Front Immunol. 2021. PMID: 34858428 Free PMC article.
Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage.
Kyuregyan KK, Lopatukhina MA, Asadi Mobarkhan FA, Kichatova VS, Potemkin IA, Isaeva OV, Karlsen AA, Malinnikova EY, Kaira AN, Kozhanova TV, Manuylov VA, Mazunina EP, Bykonia EN, Kleymenov DA, Ignateva ME, Trotsenko OE, Kuznetsova AV, Saryglar AA, Oorzhak ND, Romanenko VV, Mikhailov MI. Kyuregyan KK, et al. Among authors: bykonia en. Vaccines (Basel). 2022 Aug 29;10(9):1423. doi: 10.3390/vaccines10091423. Vaccines (Basel). 2022. PMID: 36146501 Free PMC article.
Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level.
Godkov MA, Ogarkova DA, Gushchin VA, Kleymenov DA, Mazunina EP, Bykonia EN, Pochtovyi AA, Shustov VV, Shcheblyakov DV, Komarov AG, Tsibin AN, Zlobin VI, Logunov DY, Gintsburg AL. Godkov MA, et al. Among authors: bykonia en. Vaccines (Basel). 2022 Dec 30;11(1):90. doi: 10.3390/vaccines11010090. Vaccines (Basel). 2022. PMID: 36679936 Free PMC article.
Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination.
Asadi Mobarkhan FA, Manuylov VA, Karlsen AA, Kichatova VS, Potemkin IA, Lopatukhina MA, Isaeva OV, Mullin EV, Mazunina EP, Bykonia EN, Kleymenov DA, Popova LI, Gushchin VA, Tkachuk AP, Saryglar AA, Kravchenko IE, Sleptsova SS, Romanenko VV, Kuznetsova AV, Solonin SA, Semenenko TA, Mikhailov MI, Kyuregyan KK. Asadi Mobarkhan FA, et al. Among authors: bykonia en. Vaccines (Basel). 2023 Feb 13;11(2):430. doi: 10.3390/vaccines11020430. Vaccines (Basel). 2023. PMID: 36851307 Free PMC article.
Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study.
Tkachuk AP, Bykonia EN, Popova LI, Kleymenov DA, Semashko MA, Chulanov VP, Fitilev SB, Maksimov SL, Smolyarchuk EA, Manuylov VA, Vasina DV, Gushchin VA, Gintsburg AL. Tkachuk AP, et al. Among authors: bykonia en. Vaccines (Basel). 2020 Nov 3;8(4):652. doi: 10.3390/vaccines8040652. Vaccines (Basel). 2020. PMID: 33153191 Free PMC article.